Mel Sorensen

Insider Reports History

Entity
Individual
Location
7 Rapps Run Drive, Malvern, PA
Signature
/s/ Chris Degnan, Attorney-in-Fact for J. Mel Sorensen
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Mel Sorensen:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Galera Therapeutics, Inc. President and CEO, Director Common Stock 265K $19.1K $0.07 Aug 16, 2024 Direct

Insider Reports Filed by Mel Sorensen

Symbol Company Period Transactions Value $ Form Type Date Filed Role
GRTX Galera Therapeutics, Inc. Aug 16, 2024 1 -$4.83K 4 Aug 20, 2024 President and CEO, Director
GRTX Galera Therapeutics, Inc. Mar 10, 2023 1 $168K 4 Mar 14, 2023 President and CEO, Director
GRTX Galera Therapeutics, Inc. Feb 25, 2023 1 $0 4 Feb 28, 2023 President and CEO, Director
GRTX Galera Therapeutics, Inc. Feb 28, 2022 1 $0 4 Mar 2, 2022 President and CEO, Director